视网膜疾病的神经保护策略
本文综述了促进神经元存活、有望防止视力丧失和视网膜细胞死亡的神经保护策略,限于作者实验室有直接经验的方法,包括靶向存活通路的药物(如熊去氧胆酸UDCA和牛磺熊去氧胆酸TUDCA等胆汁酸、孕酮等类固醇激素、靶向视网膜多巴胺的疗法和神经营养因子)以及增强内源性修复机制的康复方法(如运动和电刺激疗法);文中为每种方法提供了背景、潜在机制、视网膜动物和人体研究综述,并讨论了临床转化考虑。
要点
- 综述聚焦作者实验室有直接经验的神经保护策略,包括胆汁酸、类固醇激素、靶向视网膜多巴胺疗法、神经营养因子、运动和电刺激。
- 尽管视网膜疾病发病率高且机制复杂,若干有前景的神经保护治疗为预防失明带来希望。
核心结论
- 尽管视网膜疾病发病率高且机制复杂,若干有前景的神经保护治疗为预防失明带来希望。
- 作者讨论了有吸引力的候选方案,目标是推进关键领域的视网膜研究,以快速将神经保护策略转化到临床。
研究设计与样本
- 综述;因神经保护策略数量众多,将综述范围限制在作者实验室有直接经验的方法。
主要发现
- 视力丧失影响患者生活质量,并给个人和整个医疗系统带来经济负担。
- 尽管迫切需要治疗,目前临床上有效的选择很少。
- 综述聚焦靶向存活通路的药物,包括熊去氧胆酸(UDCA)和牛磺熊去氧胆酸(TUDCA)等胆汁酸、孕酮等类固醇激素、靶向视网膜多巴胺的疗法和神经营养因子。
- 综述还涵盖增强内源性修复机制的康复方法,包括运动和电刺激疗法。
关键数值与推荐
- 对每种方法,提供神经保护策略的背景,包括在其他疾病中的使用历史。
- 对每种方法,描述潜在作用机制。
- 对每种方法,综述迄今在视网膜中进行的动物和人体研究。
- 对每种方法,讨论将每种治疗转化到临床和视网膜时的考虑,包括哪些疗法对每种视网膜疾病显示出最大希望。
临床怎么用
- 原文未据此给出推荐。
局限性
- 因神经保护策略数量众多,将综述范围限制在作者实验室有直接经验的方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diseases that affect the eye, including photoreceptor degeneration, diabetic retinopathy, and glaucoma, affect 11.8 million people in the US, resulting in vision loss and blindness. Loss of sight affects patient quality of life and puts an economic burden both on individuals and the greater healthcare system. Despite the urgent need for treatments, few effective options currently exist in the clinic. Here, we review research on promising neuroprotective strategies that promote neuronal survival with the potential to protect against vision loss and retinal cell death. Due to the large number of neuroprotective strategies, we restricted our review to approaches that we had direct experience with in the laboratory. We focus on drugs that target survival pathways, including bile acids like UDCA and TUDCA, steroid hormones like progesterone, therapies that target retinal dopamine, and neurotrophic factors. In addition, we review rehabilitative methods that increase endogenous repair mechanisms, including exercise and electrical stimulation therapies. For each approach, we provide background on the neuroprotective strategy, including history of use in other diseases; describe potential mechanisms of action; review the body of research performed in the retina thus far, both in animals and in humans; and discuss considerations when translating each treatment to the clinic and to the retina, including which therapies show the most promise for each retinal disease. Despite the high incidence of retinal diseases and the complexity of mechanisms involved, several promising neuroprotective treatments provide hope to prevent blindness. We discuss attractive candidates here with the goal of furthering retinal research in critical areas to rapidly translate neuroprotective strategies into the clinic.
引用
- Pardue MT, Allen RS. Neuroprotective strategies for retinal disease. Prog Retin Eye Res. 2018. PMID: 29481975. doi:10.1016/j.preteyeres.2018.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。